pfizer guidance

Pfizer Joins Other Pharmas in Giving a Cautious Outlook

Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What's ahead for the world's biggest drugmaker:

Pfizer Earnings Rise 9%, Topping Estimates

Pfizer (PFE) reported Tuesday that its second-quarter profit increased 9%, handily beating analyst expectations, as it further cut costs and revenue jumped sharply due to its acquisition of Wyeth last October.